Court rules in favour of Zydus' copy of Shire's controlled-release UC drug
Shire says it will appeal a decision invalidating a patent surrounding the controlled-release composition of its ulcerative colitis drug Lialda (mesalazine).
Archives for September 18, 2016
ICON completes ClinicalRM acquisition
The acquisition, which was announced in June of this year, has been completed, expanding the company’s reach into government sponsored research.
Pii faces EU ban following GMP issues at Maryland facilities
The EMA has recommended a European ban of all non-critical drugs made by US CMO Pharmaceutics International Inc (Pii).
Drug development consultancy Certara focusing on 'value based development'
Through its acquisition of d3 Medicine, Certara has expanded its Strategic Consulting (CSC) division, which uses a range of methods to support drug development.
iCardiac collaborating with Japanese SMO to conduct cardiac safety studies
iCardiac Technologies and SNBL CPC Japan, a Japanese-based Site Management Organization (SMO), will collaborate on cardiac safety studies in the country.